KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $0.94.

  • Abbott Laboratories' EPS (Basic) changed 0.0% to $0.94 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0, marking a year-over-year increase of 14242.42%. This contributed to the annual value of $7.7 for FY2024, which is 13482.62% up from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' EPS (Basic) is $0.94, which was down 0.0% from $1.02 recorded in Q2 2025.
  • Abbott Laboratories' EPS (Basic)'s 5-year high stood at $5.3 during Q4 2024, with a 5-year trough of $0.59 in Q4 2022.
  • In the last 5 years, Abbott Laboratories' EPS (Basic) had a median value of $0.92 in 2023 and averaged $1.14.
  • Per our database at Business Quant, Abbott Laboratories' EPS (Basic) tumbled by 4732.14% in 2022 and then surged by 47652.42% in 2024.
  • Quarter analysis of 5 years shows Abbott Laboratories' EPS (Basic) stood at $1.12 in 2021, then tumbled by 47.32% to $0.59 in 2022, then skyrocketed by 55.93% to $0.92 in 2023, then surged by 476.52% to $5.3 in 2024, then tumbled by 82.28% to $0.94 in 2025.
  • Its last three reported values are $0.94 in Q3 2025, $1.02 for Q2 2025, and $0.76 during Q1 2025.